Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.
about
Prognostic value of proliferation in invasive breast cancer: a reviewAdvances in molecular imaging for breast cancer detection and characterizationHow reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and GynecopathologistsInterlaboratory reproducibility of the immunocytochemical assessment of oestrogen and progesterone receptors and proliferative activity in fine needle aspiration of breast cancer.Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset.Histological evaluation of AMPK signalling in primary breast cancerEffects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trialRoutinely available indicators of prognosis in breast cancer.Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer.Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.Preoperative assessment of prognostic factors in breast cancer.Ki67 protein: the immaculate deception?Predictive and prognostic markers for invasive breast cancer.Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.Molecular imaging research in the outcomes era: measuring outcomes for individualized cancer therapyKi-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical reviewKi-67 biomarker in breast cancer of Indian womenAssociations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based studyMIB-1 labelling index is an independent prognostic marker in primary breast cancer.Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy.Cell proliferation measured by MIB1 and timing of surgery for breast cancer.Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinomaOrthotopic transplantation model of human gastrointestinal cancer and detection of micrometastasesPrognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material.Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma.CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer.The aged breast.Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryInflammatory cell infiltration of tumors: Jekyll or Hyde.High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association ConsortiumTumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.Proliferative activity in invasive breast carcinomaMIB-1 proliferative activity in invasive breast cancer measured by image analysis.Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.Correlation between Ki67 and breast cancer prognosis.
P2860
Q24672660-001FDCB7-6813-4974-8866-3860A62C1E7EQ27000462-B46DBF8C-4F57-468D-8C99-267F8E17960DQ28729183-36E7BA0B-A89E-491D-8092-933366A2AB43Q30832008-EF8F6938-C16D-43C9-A454-459EACF6D9ACQ31153510-E81A0156-9539-443A-B152-BB96520C12CEQ33499119-F1B7B991-4293-4E6F-8AA3-8192658E1F62Q33513057-7F672851-24EC-47E4-832D-6057FD1FA76EQ33539150-894E4595-4ECA-4C6B-AFBA-65F6C105CAD9Q33801758-AD1D82F1-339B-4B40-9632-F96059F76D0EQ33919277-19643CF7-94FF-4579-8ECE-D547471C18B7Q34197110-31B70266-95C8-4CF4-9FD6-BE2D43867BBCQ34570709-760DCD2C-14A8-4162-AEAC-42B39EB91D14Q34612314-81220C4B-591F-4EEB-8B8F-C91F957B482DQ34744341-C278144B-2486-4892-BE00-E6D6A27E98BDQ35012858-E8052789-E210-4C56-86BC-6F7C36D1141FQ35793157-1DBAD948-74CE-40E2-B361-79F1199F9AB8Q35904441-A8145E28-FD76-42B4-B6B2-164661043724Q35913434-DE22449C-2531-4B64-BDA0-A18CC735374EQ35944405-630F8630-3141-4F6E-9CD0-7F849A8CB176Q36115384-03D97962-8C0C-4B8F-A7E6-22E2DBB12429Q36134612-BF138E09-8942-4DF7-B9C7-496F07A19506Q36175746-B705D42E-576D-4E85-BED1-831775C4E48DQ36292397-4E8D62FE-5868-4411-A1BF-8A5A6C2530DFQ36292533-04D80102-59B0-4BA0-8E11-01F69DF6F553Q36294984-6CB5A2D7-EBB0-4B99-A31D-10DEA767BC16Q36397411-78DC4E3B-62B0-4C9B-B601-1644124EC36AQ36422395-FC1FF5EB-16F3-4E3C-80F0-A1A6B9EA5A6AQ36609527-9703D691-A6D0-4F9C-B7A0-60073C6E75C2Q36617277-86E8E929-095B-45A3-BFF2-64BA97645036Q36671336-C1584849-004D-45C0-A054-4E99A1B01E4DQ36698225-2BE20751-C95F-46B8-9D82-F4E0EFFBB525Q36824352-70FDED42-BE18-400D-86BE-B22EB3852762Q36892788-B2871F4E-E3F1-416C-BE18-406C16105898Q36918692-F7931F1A-A090-43E6-9FC1-7BB82877DDD3Q37121271-C8427281-51CD-472D-8C3D-B10705C63925Q37121648-8C560BF5-8CA2-4315-9A15-784718D92ABFQ37225100-400904F9-3B73-4A8E-8978-CAEF2B2D8AF8Q37225460-2BB07C47-F5E2-456A-BDA0-82E02974DF13Q37350137-B721F810-CB9B-481B-840B-AFB0BF04E7CAQ38077896-1BE6068F-5D9F-473B-9335-F639A6881960
P2860
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Assessment of the new prolifer ...... ognostic factors and survival.
@ast
Assessment of the new prolifer ...... ognostic factors and survival.
@en
type
label
Assessment of the new prolifer ...... ognostic factors and survival.
@ast
Assessment of the new prolifer ...... ognostic factors and survival.
@en
prefLabel
Assessment of the new prolifer ...... ognostic factors and survival.
@ast
Assessment of the new prolifer ...... ognostic factors and survival.
@en
P2093
P2860
P356
P1476
Assessment of the new prolifer ...... rognostic factors and survival
@en
P2093
C W Elston
D M Sibbering
J F Robertson
R Nicholson
R W Blamey
P2860
P2888
P304
P356
10.1038/BJC.1995.30
P407
P577
1995-01-01T00:00:00Z